| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Customer Service > Gift Cards Under The Gun, is Retail the Next Target? |
|
Main Subject - Gift Cards Under The Gun, is Retail the Next Target?
The Federal Trade Commission is concerned that many companies offerin According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product g Gift Cards are not disclosing all the terms and fees. The SEC is qu ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in estioning which quarter the gift card revenue is put into? Should it lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. be listed in the fiscal quarter it is issued or the fiscal period tha here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe the consumer actually uses it? Additionally it is widely known that d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro most gift cards have balances that are never used and eventually expi ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc re. The industry average is some 15-20% and this means the companies easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi etain that as income. Now we see that Regulatory Bodies already tryi nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ng to control the growth of gift cards; and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ //www.eweek.com/article2/0,1895,2004481,00.asp?kc=EWRETEMNL082406EOAD ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi >http://www.eweek.com/article2/0,1895,2004481,00.asp?kc=EWRETEMNL0824 ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a 06EOAD This is problematic as it adds fodder to the lawyers to s dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ue companies, which may not be in compliance, it hurts smaller compan cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ies attempting to bundle services and lock in customers from their ma tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen or Box Store Outlets. Also gift cards are being used as a form of cur t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel rency by many? This electronic bartering will cause issues with the ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust currency say some forward sub-sector economists. All this is interest y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ng. But can we trust the government to regulate this, as they are mes . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de sing up everything else they regulate and in the end Always end up hu elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip rting the consumer they purport to protect? Consider all this in 2006 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Why Don't More People Claim Compensation? Job Interview Basics: How To Sell Yourself
|